Bedel Financial Consulting’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-800
Closed -$15K 960
2020
Q4
$15K Buy
800
+100
+14% +$2.19K 0.01% 497
2020
Q3
$18K Hold
700
0.01% 442
2020
Q2
$21K Hold
700
0.01% 398
2020
Q1
$22K Buy
700
+100
+17% +$4.14K 0.01% 382
2019
Q4
$27K Buy
+600
New +$24.9K 0.02% 374

Other funds holding RCEL

Bedel Financial Consulting's RCEL Position: Q1 2021 in Review

Bedel Financial Consulting sold out of Avita Medical (RCEL) in Q1 2021, closing a stake of 800 shares — an estimated $15K sold.

Bedel Financial Consulting first reported a position in RCEL in Q4 2019 and held it in 5 quarters. The position peaked at $27K in Q4 2019. 61 funds tracked by Wall St. Rank hold RCEL as of Q1 2021.

  • Bedel Financial Consulting reported no remaining Avita Medical position as of Q1 2021 after selling out during the quarter.
  • Bedel Financial Consulting sold 800 Avita Medical shares in Q1 2021, an estimated $15K.
  • Bedel Financial Consulting first reported a position in Avita Medical in Q4 2019 and held it in 5 quarters.
  • Bedel Financial Consulting's Avita Medical position peaked at $27K in Q4 2019.
  • 61 funds tracked by Wall St. Rank held Avita Medical as of Q1 2021.

Based on Bedel Financial Consulting's 13F filing for Q1 2021, filed 26 Apr 2021.